Background Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy
characterized by drug-resistant, lifelong seizures. The management of seizures in DS has …

Over 65 million people suffer from recurrent, unprovoked seizures. The lack of validated
biomarkers specific for myriad forms of epilepsy makes diagnosis challenging. Diagnosis …

Management of drug resistant epilepsy (DRE) represents a challenge to the treating
clinician. This manuscript addresses DRE and provides an overview of treatment options …

Background Endovascular treatment (EVT) is the standard of care of ischaemic stroke due to
occlusion of large vessels. Although EVT can significantly improve short-and long-term …

Fluorescence sensing is crucial to studying biological processes and diagnosing diseases,
especially in the second near‐infrared (NIR‐II) window with reduced background signals …

In 2019, over 130 people from several countries travelled to Gothenburg, Sweden, for the
Seizures and Stroke Congress, the first international conference devoted to post-stroke …

Aim To evaluate and synthesize the evidence and knowledge gaps on primary prevention
and treatment of post-stroke acute symptomatic seizures (ASSs) using antiseizure …

Stroke, epilepsy, and depression rank among the most prevalent neurological and
psychiatric disorders, yet viable treatment options remain limited (Campbell and Khatri …

Introduction: Brain histamine is considered an endogenous anticonvulsant and histamine
H1 receptor. H1R antagonists have, in earlier studies, been found to induce convulsions …

Epilepsy is a persistent neurological disorder that affects more than 70 million people
worldwide. It is characterized by a long-lasting predisposition to recurrently generate …